SCHEMBL4773810

SCHEMBL4773810

CCCCC(=O)OCOC(=O)c1c(S)c(N2CCCC2)c(Oc2ccccc2)c(S(N)(=O)=O)c1S

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 2/20 0.38
USP2 O75604 2/20 0.38
LMNA P02545 2/20 0.38
HPGD P15428 2/20 0.38
HIF1A Q16665 2/20 0.38
HSD17B10 Q99714 2/20 0.38
SLC6A4 P31645 1/20 0.38
CA2 P00918 2/20 0.35
TSHR P16473 1/20 0.35
BLM P54132 1/20 0.35
SLC12A2 P55011 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PTGS2 P35354 3/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA7 P43166 1/20 0.32
CA13 Q8N1Q1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL230347 0.86 ALDH1A1 (0.41) ALDH1A1KDM4EUSP2LMNAHPGD
SCHEMBL230175 0.83 KDM4E (0.45) ALDH1A1KDM4EUSP2LMNAHPGD
SCHEMBL1739520 0.81 LMNA (0.45) ALDH1A1KDM4EUSP2LMNAHPGD
SCHEMBL230213 0.81 ALDH1A1 (0.51) ALDH1A1KDM4EUSP2LMNAHPGD
SCHEMBL231099 0.68 KDM4E (0.50) ALDH1A1KDM4EUSP2LMNAHPGD
SCHEMBL232305 0.66 ALDH1A1 (0.70) ALDH1A1KDM4EUSP2LMNAHPGD
SCHEMBL4773807 0.66 ALDH1A1 (0.60) ALDH1A1KDM4EUSP2LMNAHPGD
SCHEMBL231978 0.66 CA2 (0.54) ALDH1A1KDM4EUSP2LMNAHPGD
SCHEMBL4014213 0.65 CA2 (0.74) ALDH1A1KDM4EUSP2LMNAHPGD
SCHEMBL2696224 0.63 ALDH1A1 (0.48) ALDH1A1KDM4EUSP2LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1951702-A2 DIURETIC-LIKE COMPOUND ANALOGS USEFUL FOR REGULATION OF CENTRAL NERVOUS SYSTEM DISORDERS NeuroTherapeutics Pharma, Inc. (US) 2008-08-06 EP disclosed
EP-1937242-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROPSYCHIATRIC AND ADDICTIVE DISORDERS NeuroTherapeutics Pharma, Inc. (US) 2008-07-02 EP disclosed
WO-2007047447-A2 DIURETIC-LIKE COMPOUND ANALOGS USEFUL FOR REGULATION OF CENTRAL NERVOUS SYSTEM DISORDERS NEUROTHERAPEUTICS PHARMA, INC. (US) 2007-04-26 WO disclosed
WO-2007047698-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROPSYCHIATRIC AND ADDICTIVE DISORDERS NEUROTHERAPEUTICS PHARMA, INC. (US) 2007-04-26 WO disclosed